IOBT
IO Biotech, Inc.
Key Financials
Operating Income
$-95177000
↓ 4.1%
Total Assets
$67.7M
↓ 55.1%
Net Income
$-95491000
↓ 10.9%
EPS (Diluted)
$-1.45
↑ 26.8%
Shareholders' Equity
$47.0M
↓ 64.7%
Cash & Equivalents
$60.0M
↓ 58.1%
Long-term Debt
$0.00
N/A
Total Liabilities
$20.7M
↑ 17.8%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 25-NSE | 6/8/2026 | View on SEC |
| SCHEDULE 13D/A | 6/2/2026 | View on SEC |
| SCHEDULE 13G/A | 5/20/2026 | View on SEC |
| SCHEDULE 13G/A | 5/15/2026 | View on SEC |
| SCHEDULE 13G/A | 4/6/2026 | View on SEC |
| 8-K | 3/31/2026 | View on SEC |
| 8-K | 2/13/2026 | View on SEC |
| SCHEDULE 13G/A | 2/13/2026 | View on SEC |
| SCHEDULE 13G | 2/6/2026 | View on SEC |
| 8-K | 1/30/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | IOBT |
| Company Name | IO Biotech, Inc. |
| CIK | 1865494 |
| Sector | Pharmaceutical Preparations |
| Industry | Emerging growth company |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 4570702980 |